A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity-Reference-Cited by-同舟云学术

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity

Published:2022-02 Issue: Volume:49 Page:102219
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Xiao Mengjie,Tang Yufeng,Wang Jie,Lu Guangping,Niu Jianlou,Wang Jie,Li Jiahao,Liu Qingbo,Wang Zhaoyun,Huang Zhifeng,Guo Yuanfang,Gao Ting,Zhang Xiaohui,Yue Shouwei,Gu Junlian

Funder

Shandong University

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference53 articles.

1. Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways;Wang;Cell. Mol. Life Sci.,2021

2. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT;Zhang;Cell Death Differ.,2020

3. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies;Octavia;J. Mol. Cell. Cardiol.,2012

4. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2;Zhao;Redox Biol.,2018

5. Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology;Belov;Cold Spring Harbor Perspect. Biol.,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant activation of p53-TRIB3 axis contributes to diabetic myocardial insulin resistance and sulforaphane protection;Journal of Advanced Research;2024-07

2. Elevation of p53 sensitizes obese kidney to adriamycin-induced aberrant lipid homeostasis via repressing HNF4α-mediated FGF21 sensitivity;Journal of Advanced Research;2024-07

3. Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve;Current Medicinal Chemistry;2024-06-24

4. Marein Alleviates Doxorubicin-Induced Cardiotoxicity through FAK/AKT Pathway Modulation while Potentiating its Anticancer Activity;Cardiovascular Toxicology;2024-06-19

5. FGF1-based Drugs for The Treatment of Obesity-related Complications;PROG BIOCHEM BIOPHYS;2024